Amedisys Reports Third Quarter 2019 Financial Results and Updates 2019 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St mixed as benchmark Treasury yields reach 5%, oil takes a pause
- Oil slides following outreach to Iran to limit Houthis actions in Red Sea
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Amedisys (AMED) Tops Q3 EPS by 26c
October 29, 2019 4:09 PM EDTAmedisys (NASDAQ: AMED) reported Q3 EPS of $1.15, $0.26 better than the analyst estimate of $0.89. Revenue for the quarter came in at $494.6 million versus the consensus estimate of $494.16 million.
GUIDANCE:
Amedisys sees FY2019 EPS of $4.32-$4.39, versus the consensus of $4.15. Amedisys sees... More
